nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—GPCRs, Other—S1PR1—multiple sclerosis	0.0112	0.07	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR1—multiple sclerosis	0.00975	0.0609	CbGpPWpGaD
Degarelix—GNRHR—brainstem—multiple sclerosis	0.0068	0.342	CbGeAlD
Degarelix—GNRHR—Peptide GPCRs—CXCR3—multiple sclerosis	0.00646	0.0403	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR2—multiple sclerosis	0.00628	0.0392	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—CXCR3—multiple sclerosis	0.00547	0.0342	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00508	0.0317	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—CNR1—multiple sclerosis	0.00491	0.0307	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00454	0.0284	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00417	0.026	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR5—multiple sclerosis	0.00405	0.0253	CbGpPWpGaD
Degarelix—GNRHR—nervous system—multiple sclerosis	0.00356	0.179	CbGeAlD
Degarelix—GNRHR—GPCRs, Other—CCR5—multiple sclerosis	0.00343	0.0214	CbGpPWpGaD
Degarelix—GNRHR—central nervous system—multiple sclerosis	0.00343	0.173	CbGeAlD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00336	0.021	CbGpPWpGaD
Degarelix—GNRHR—cerebellum—multiple sclerosis	0.00335	0.169	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—S1PR1—multiple sclerosis	0.00318	0.0198	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00307	0.0192	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00307	0.0192	CbGpPWpGaD
Degarelix—GNRHR—brain—multiple sclerosis	0.00272	0.137	CbGeAlD
Degarelix—GNRHR—GPCR ligand binding—GPR65—multiple sclerosis	0.00256	0.016	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCL13—multiple sclerosis	0.00234	0.0146	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR1—multiple sclerosis	0.00234	0.0146	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00219	0.0137	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00211	0.0132	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00204	0.0127	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00198	0.0124	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00183	0.0114	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00179	0.0112	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL3—multiple sclerosis	0.00167	0.0104	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00165	0.0103	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—S1PR1—multiple sclerosis	0.00163	0.0102	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—PTGER4—multiple sclerosis	0.00161	0.01	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCR3—multiple sclerosis	0.00155	0.00969	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—RGS1—multiple sclerosis	0.00153	0.00953	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR2—multiple sclerosis	0.00151	0.00942	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GPR65—multiple sclerosis	0.00145	0.00904	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00142	0.00885	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CNR1—multiple sclerosis	0.00139	0.0087	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—RGS1—multiple sclerosis	0.00139	0.00866	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR1—multiple sclerosis	0.00132	0.00826	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00132	0.00826	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GPR65—multiple sclerosis	0.00131	0.00821	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00128	0.00797	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LINGO1—multiple sclerosis	0.00127	0.00793	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCL10—multiple sclerosis	0.00125	0.00783	CbGpPWpGaD
Degarelix—Eye disorder—Dexamethasone—multiple sclerosis	0.00124	0.00151	CcSEcCtD
Degarelix—Back pain—Triamcinolone—multiple sclerosis	0.00123	0.0015	CcSEcCtD
Degarelix—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00123	0.0015	CcSEcCtD
Degarelix—Angiopathy—Dexamethasone—multiple sclerosis	0.00121	0.00147	CcSEcCtD
Degarelix—Angiopathy—Betamethasone—multiple sclerosis	0.00121	0.00147	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCR1—multiple sclerosis	0.0012	0.0075	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CXCL13—multiple sclerosis	0.0012	0.0075	CbGpPWpGaD
Degarelix—Decreased appetite—Mitoxantrone—multiple sclerosis	0.0012	0.00146	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.0012	0.00748	CbGpPWpGaD
Degarelix—Hypertension—Prednisolone—multiple sclerosis	0.0012	0.00146	CcSEcCtD
Degarelix—Fatigue—Mitoxantrone—multiple sclerosis	0.00119	0.00145	CcSEcCtD
Degarelix—Arrhythmia—Dexamethasone—multiple sclerosis	0.00119	0.00145	CcSEcCtD
Degarelix—Arrhythmia—Betamethasone—multiple sclerosis	0.00119	0.00145	CcSEcCtD
Degarelix—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Degarelix—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Degarelix—Pain—Mitoxantrone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Degarelix—Constipation—Mitoxantrone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Degarelix—Alopecia—Dexamethasone—multiple sclerosis	0.00117	0.00143	CcSEcCtD
Degarelix—Alopecia—Betamethasone—multiple sclerosis	0.00117	0.00143	CcSEcCtD
Degarelix—Diarrhoea—Azathioprine—multiple sclerosis	0.00117	0.00142	CcSEcCtD
Degarelix—Discomfort—Prednisolone—multiple sclerosis	0.00117	0.00142	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00116	0.00141	CcSEcCtD
Degarelix—Erythema—Betamethasone—multiple sclerosis	0.00116	0.00141	CcSEcCtD
Degarelix—Erythema—Dexamethasone—multiple sclerosis	0.00116	0.00141	CcSEcCtD
Degarelix—Malaise—Triamcinolone—multiple sclerosis	0.00115	0.0014	CcSEcCtD
Degarelix—Malaise—Methylprednisolone—multiple sclerosis	0.00115	0.0014	CcSEcCtD
Degarelix—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00114	0.00139	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Degarelix—Dysuria—Methotrexate—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Degarelix—Dizziness—Azathioprine—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Degarelix—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00111	0.00136	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—TAGAP—multiple sclerosis	0.0011	0.00688	CbGpPWpGaD
Degarelix—Hypertension—Triamcinolone—multiple sclerosis	0.0011	0.00134	CcSEcCtD
Degarelix—Hypertension—Methylprednisolone—multiple sclerosis	0.0011	0.00134	CcSEcCtD
Degarelix—Urticaria—Mitoxantrone—multiple sclerosis	0.0011	0.00134	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00109	0.00133	CcSEcCtD
Degarelix—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00109	0.00133	CcSEcCtD
Degarelix—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00109	0.00133	CcSEcCtD
Degarelix—Vomiting—Azathioprine—multiple sclerosis	0.00108	0.00132	CcSEcCtD
Degarelix—Arthralgia—Methylprednisolone—multiple sclerosis	0.00108	0.00132	CcSEcCtD
Degarelix—Eye disorder—Prednisone—multiple sclerosis	0.00108	0.00132	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CCL5—multiple sclerosis	0.00108	0.00674	CbGpPWpGaD
Degarelix—Rash—Azathioprine—multiple sclerosis	0.00108	0.00131	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00108	0.00131	CcSEcCtD
Degarelix—Dermatitis—Azathioprine—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Depression—Methotrexate—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Discomfort—Triamcinolone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Discomfort—Methylprednisolone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Degarelix—Headache—Azathioprine—multiple sclerosis	0.00107	0.0013	CcSEcCtD
Degarelix—Dry mouth—Triamcinolone—multiple sclerosis	0.00106	0.00129	CcSEcCtD
Degarelix—Renal failure—Methotrexate—multiple sclerosis	0.00106	0.00129	CcSEcCtD
Degarelix—Angiopathy—Prednisone—multiple sclerosis	0.00105	0.00128	CcSEcCtD
Degarelix—Immune system disorder—Prednisone—multiple sclerosis	0.00105	0.00127	CcSEcCtD
Degarelix—Malaise—Dexamethasone—multiple sclerosis	0.00104	0.00127	CcSEcCtD
Degarelix—Malaise—Betamethasone—multiple sclerosis	0.00104	0.00127	CcSEcCtD
Degarelix—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00104	0.00127	CcSEcCtD
Degarelix—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00104	0.00127	CcSEcCtD
Degarelix—Arrhythmia—Prednisone—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Degarelix—Insomnia—Prednisolone—multiple sclerosis	0.00102	0.00125	CcSEcCtD
Degarelix—Alopecia—Prednisone—multiple sclerosis	0.00102	0.00125	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00102	0.00124	CcSEcCtD
Degarelix—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00102	0.00124	CcSEcCtD
Degarelix—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00102	0.00124	CcSEcCtD
Degarelix—Mental disorder—Prednisone—multiple sclerosis	0.00101	0.00124	CcSEcCtD
Degarelix—Nausea—Azathioprine—multiple sclerosis	0.00101	0.00124	CcSEcCtD
Degarelix—Skin disorder—Methylprednisolone—multiple sclerosis	0.00101	0.00123	CcSEcCtD
Degarelix—Erythema—Prednisone—multiple sclerosis	0.00101	0.00123	CcSEcCtD
Degarelix—Malnutrition—Prednisone—multiple sclerosis	0.00101	0.00123	CcSEcCtD
Degarelix—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00101	0.00123	CcSEcCtD
Degarelix—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.001	0.00122	CcSEcCtD
Degarelix—Hypertension—Dexamethasone—multiple sclerosis	0.000999	0.00122	CcSEcCtD
Degarelix—Hypertension—Betamethasone—multiple sclerosis	0.000999	0.00122	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000998	0.00623	CbGpPWpGaD
Degarelix—Asthenia—Mitoxantrone—multiple sclerosis	0.00099	0.00121	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000976	0.0061	CbGpPWpGaD
Degarelix—Discomfort—Betamethasone—multiple sclerosis	0.000973	0.00119	CcSEcCtD
Degarelix—Discomfort—Dexamethasone—multiple sclerosis	0.000973	0.00119	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CCR5—multiple sclerosis	0.000972	0.00607	CbGpPWpGaD
Degarelix—Hypotension—Methylprednisolone—multiple sclerosis	0.00097	0.00118	CcSEcCtD
Degarelix—Pain—Prednisolone—multiple sclerosis	0.000968	0.00118	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—S1PR1—multiple sclerosis	0.000963	0.00601	CbGpPWpGaD
Degarelix—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000955	0.00116	CcSEcCtD
Degarelix—Vision blurred—Prednisone—multiple sclerosis	0.00095	0.00116	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—multiple sclerosis	0.000948	0.00116	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000948	0.00116	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000946	0.00115	CcSEcCtD
Degarelix—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000944	0.00115	CcSEcCtD
Degarelix—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000944	0.00115	CcSEcCtD
Degarelix—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000944	0.00115	CcSEcCtD
Degarelix—Insomnia—Triamcinolone—multiple sclerosis	0.000941	0.00115	CcSEcCtD
Degarelix—Insomnia—Methylprednisolone—multiple sclerosis	0.000939	0.00115	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GPC5—multiple sclerosis	0.000937	0.00585	CbGpPWpGaD
Degarelix—Ill-defined disorder—Prednisone—multiple sclerosis	0.000935	0.00114	CcSEcCtD
Degarelix—Feeling abnormal—Prednisolone—multiple sclerosis	0.000933	0.00114	CcSEcCtD
Degarelix—Anaemia—Prednisone—multiple sclerosis	0.000931	0.00114	CcSEcCtD
Degarelix—Dyspnoea—Triamcinolone—multiple sclerosis	0.000928	0.00113	CcSEcCtD
Degarelix—Nervous system disorder—Betamethasone—multiple sclerosis	0.000926	0.00113	CcSEcCtD
Degarelix—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000926	0.00113	CcSEcCtD
Degarelix—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000913	0.00111	CcSEcCtD
Degarelix—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000913	0.00111	CcSEcCtD
Degarelix—Malaise—Prednisone—multiple sclerosis	0.000909	0.00111	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000908	0.00567	CbGpPWpGaD
Degarelix—Eye disorder—Methotrexate—multiple sclerosis	0.000904	0.0011	CcSEcCtD
Degarelix—Urticaria—Prednisolone—multiple sclerosis	0.000899	0.0011	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—multiple sclerosis	0.000898	0.00109	CcSEcCtD
Degarelix—Fatigue—Triamcinolone—multiple sclerosis	0.000897	0.00109	CcSEcCtD
Degarelix—Fatigue—Methylprednisolone—multiple sclerosis	0.000895	0.00109	CcSEcCtD
Degarelix—Pain—Triamcinolone—multiple sclerosis	0.00089	0.00109	CcSEcCtD
Degarelix—Hypotension—Betamethasone—multiple sclerosis	0.000882	0.00108	CcSEcCtD
Degarelix—Hypotension—Dexamethasone—multiple sclerosis	0.000882	0.00108	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—multiple sclerosis	0.000878	0.00107	CcSEcCtD
Degarelix—Vomiting—Mitoxantrone—multiple sclerosis	0.000877	0.00107	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000877	0.00547	CbGpPWpGaD
Degarelix—Immune system disorder—Methotrexate—multiple sclerosis	0.000874	0.00107	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000872	0.00106	CcSEcCtD
Degarelix—Hypertension—Prednisone—multiple sclerosis	0.00087	0.00106	CcSEcCtD
Degarelix—Rash—Mitoxantrone—multiple sclerosis	0.00087	0.00106	CcSEcCtD
Degarelix—Dermatitis—Mitoxantrone—multiple sclerosis	0.000869	0.00106	CcSEcCtD
Degarelix—Chills—Methotrexate—multiple sclerosis	0.000868	0.00106	CcSEcCtD
Degarelix—Headache—Mitoxantrone—multiple sclerosis	0.000864	0.00105	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00086	0.00105	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00086	0.00105	CcSEcCtD
Degarelix—Arthralgia—Prednisone—multiple sclerosis	0.000858	0.00105	CcSEcCtD
Degarelix—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000858	0.00105	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCL3—multiple sclerosis	0.000856	0.00535	CbGpPWpGaD
Degarelix—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000856	0.00104	CcSEcCtD
Degarelix—Alopecia—Methotrexate—multiple sclerosis	0.000855	0.00104	CcSEcCtD
Degarelix—Insomnia—Dexamethasone—multiple sclerosis	0.000854	0.00104	CcSEcCtD
Degarelix—Insomnia—Betamethasone—multiple sclerosis	0.000854	0.00104	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000853	0.00533	CbGpPWpGaD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000852	0.00104	CcSEcCtD
Degarelix—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000849	0.00104	CcSEcCtD
Degarelix—Discomfort—Prednisone—multiple sclerosis	0.000848	0.00103	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—multiple sclerosis	0.000847	0.00103	CcSEcCtD
Degarelix—Erythema—Methotrexate—multiple sclerosis	0.000842	0.00103	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—multiple sclerosis	0.000842	0.00103	CcSEcCtD
Degarelix—Hypersensitivity—Prednisolone—multiple sclerosis	0.000834	0.00102	CcSEcCtD
Degarelix—Urticaria—Triamcinolone—multiple sclerosis	0.000827	0.00101	CcSEcCtD
Degarelix—Urticaria—Methylprednisolone—multiple sclerosis	0.000825	0.00101	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000824	0.00515	CbGpPWpGaD
Degarelix—Body temperature increased—Triamcinolone—multiple sclerosis	0.000823	0.001	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisone—multiple sclerosis	0.000822	0.001	CcSEcCtD
Degarelix—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000821	0.001	CcSEcCtD
Degarelix—Decreased appetite—Dexamethasone—multiple sclerosis	0.000821	0.001	CcSEcCtD
Degarelix—Decreased appetite—Betamethasone—multiple sclerosis	0.000821	0.001	CcSEcCtD
Degarelix—Nausea—Mitoxantrone—multiple sclerosis	0.000819	0.000999	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—RGS1—multiple sclerosis	0.000819	0.00511	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000815	0.000994	CcSEcCtD
Degarelix—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000815	0.000994	CcSEcCtD
Degarelix—Back pain—Methotrexate—multiple sclerosis	0.000815	0.000993	CcSEcCtD
Degarelix—Fatigue—Betamethasone—multiple sclerosis	0.000814	0.000993	CcSEcCtD
Degarelix—Fatigue—Dexamethasone—multiple sclerosis	0.000814	0.000993	CcSEcCtD
Degarelix—Pain—Betamethasone—multiple sclerosis	0.000807	0.000985	CcSEcCtD
Degarelix—Pain—Dexamethasone—multiple sclerosis	0.000807	0.000985	CcSEcCtD
Degarelix—Nervous system disorder—Prednisone—multiple sclerosis	0.000806	0.000983	CcSEcCtD
Degarelix—Skin disorder—Prednisone—multiple sclerosis	0.000799	0.000974	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000796	0.00497	CbGpPWpGaD
Degarelix—Hyperhidrosis—Prednisone—multiple sclerosis	0.000795	0.000969	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—multiple sclerosis	0.000794	0.000968	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000787	0.00491	CbGpPWpGaD
Degarelix—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000781	0.000953	CcSEcCtD
Degarelix—Anaemia—Methotrexate—multiple sclerosis	0.000778	0.000949	CcSEcCtD
Degarelix—Feeling abnormal—Betamethasone—multiple sclerosis	0.000778	0.000949	CcSEcCtD
Degarelix—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000778	0.000949	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GPR65—multiple sclerosis	0.000776	0.00485	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR2—multiple sclerosis	0.000774	0.00484	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000772	0.000942	CcSEcCtD
Degarelix—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000772	0.000942	CcSEcCtD
Degarelix—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000767	0.000935	CcSEcCtD
Degarelix—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000765	0.000933	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000762	0.00476	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—POMC—multiple sclerosis	0.00076	0.00475	CbGpPWpGaD
Degarelix—Malaise—Methotrexate—multiple sclerosis	0.000759	0.000926	CcSEcCtD
Degarelix—Urticaria—Betamethasone—multiple sclerosis	0.00075	0.000915	CcSEcCtD
Degarelix—Urticaria—Dexamethasone—multiple sclerosis	0.00075	0.000915	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000749	0.000914	CcSEcCtD
Degarelix—Dizziness—Prednisolone—multiple sclerosis	0.000748	0.000913	CcSEcCtD
Degarelix—Asthenia—Triamcinolone—multiple sclerosis	0.000747	0.000911	CcSEcCtD
Degarelix—Body temperature increased—Dexamethasone—multiple sclerosis	0.000746	0.00091	CcSEcCtD
Degarelix—Abdominal pain—Dexamethasone—multiple sclerosis	0.000746	0.00091	CcSEcCtD
Degarelix—Body temperature increased—Betamethasone—multiple sclerosis	0.000746	0.00091	CcSEcCtD
Degarelix—Abdominal pain—Betamethasone—multiple sclerosis	0.000746	0.00091	CcSEcCtD
Degarelix—Asthenia—Methylprednisolone—multiple sclerosis	0.000745	0.000908	CcSEcCtD
Degarelix—Insomnia—Prednisone—multiple sclerosis	0.000744	0.000907	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CCL2—multiple sclerosis	0.000744	0.00464	CbGpPWpGaD
Degarelix—Pruritus—Triamcinolone—multiple sclerosis	0.000736	0.000898	CcSEcCtD
Degarelix—Pruritus—Methylprednisolone—multiple sclerosis	0.000735	0.000896	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—multiple sclerosis	0.000717	0.000874	CcSEcCtD
Degarelix—Decreased appetite—Prednisone—multiple sclerosis	0.000715	0.000872	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CNR1—multiple sclerosis	0.000715	0.00446	CbGpPWpGaD
Degarelix—Rash—Prednisolone—multiple sclerosis	0.000713	0.00087	CcSEcCtD
Degarelix—Dermatitis—Prednisolone—multiple sclerosis	0.000713	0.000869	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000712	0.000868	CcSEcCtD
Degarelix—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00071	0.000866	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CXCL13—multiple sclerosis	0.00071	0.00443	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR1—multiple sclerosis	0.00071	0.00443	CbGpPWpGaD
Degarelix—Fatigue—Prednisone—multiple sclerosis	0.000709	0.000865	CcSEcCtD
Degarelix—Headache—Prednisolone—multiple sclerosis	0.000709	0.000865	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000709	0.00442	CbGpPWpGaD
Degarelix—Discomfort—Methotrexate—multiple sclerosis	0.000708	0.000864	CcSEcCtD
Degarelix—Constipation—Prednisone—multiple sclerosis	0.000703	0.000858	CcSEcCtD
Degarelix—Dizziness—Triamcinolone—multiple sclerosis	0.000688	0.000839	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000687	0.000838	CcSEcCtD
Degarelix—Dizziness—Methylprednisolone—multiple sclerosis	0.000687	0.000837	CcSEcCtD
Degarelix—Feeling abnormal—Prednisone—multiple sclerosis	0.000678	0.000826	CcSEcCtD
Degarelix—Asthenia—Dexamethasone—multiple sclerosis	0.000677	0.000826	CcSEcCtD
Degarelix—Asthenia—Betamethasone—multiple sclerosis	0.000677	0.000826	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—multiple sclerosis	0.000674	0.000822	CcSEcCtD
Degarelix—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000672	0.00082	CcSEcCtD
Degarelix—Nausea—Prednisolone—multiple sclerosis	0.000672	0.00082	CcSEcCtD
Degarelix—Pruritus—Betamethasone—multiple sclerosis	0.000668	0.000815	CcSEcCtD
Degarelix—Pruritus—Dexamethasone—multiple sclerosis	0.000668	0.000815	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—multiple sclerosis	0.000668	0.000814	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000664	0.00081	CcSEcCtD
Degarelix—Vomiting—Triamcinolone—multiple sclerosis	0.000662	0.000807	CcSEcCtD
Degarelix—Vomiting—Methylprednisolone—multiple sclerosis	0.00066	0.000805	CcSEcCtD
Degarelix—Rash—Triamcinolone—multiple sclerosis	0.000656	0.0008	CcSEcCtD
Degarelix—Dermatitis—Triamcinolone—multiple sclerosis	0.000656	0.000799	CcSEcCtD
Degarelix—Rash—Methylprednisolone—multiple sclerosis	0.000655	0.000798	CcSEcCtD
Degarelix—Dermatitis—Methylprednisolone—multiple sclerosis	0.000654	0.000798	CcSEcCtD
Degarelix—Urticaria—Prednisone—multiple sclerosis	0.000653	0.000797	CcSEcCtD
Degarelix—Headache—Triamcinolone—multiple sclerosis	0.000652	0.000795	CcSEcCtD
Degarelix—Headache—Methylprednisolone—multiple sclerosis	0.00065	0.000793	CcSEcCtD
Degarelix—Body temperature increased—Prednisone—multiple sclerosis	0.00065	0.000793	CcSEcCtD
Degarelix—Abdominal pain—Prednisone—multiple sclerosis	0.00065	0.000793	CcSEcCtD
Degarelix—Diarrhoea—Dexamethasone—multiple sclerosis	0.000646	0.000788	CcSEcCtD
Degarelix—Diarrhoea—Betamethasone—multiple sclerosis	0.000646	0.000788	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000643	0.00402	CbGpPWpGaD
Degarelix—Hypotension—Methotrexate—multiple sclerosis	0.000642	0.000783	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000626	0.000764	CcSEcCtD
Degarelix—Dizziness—Dexamethasone—multiple sclerosis	0.000624	0.000761	CcSEcCtD
Degarelix—Dizziness—Betamethasone—multiple sclerosis	0.000624	0.000761	CcSEcCtD
Degarelix—Insomnia—Methotrexate—multiple sclerosis	0.000622	0.000758	CcSEcCtD
Degarelix—Nausea—Triamcinolone—multiple sclerosis	0.000618	0.000754	CcSEcCtD
Degarelix—Nausea—Methylprednisolone—multiple sclerosis	0.000617	0.000752	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—multiple sclerosis	0.000613	0.000747	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCL5—multiple sclerosis	0.00061	0.00381	CbGpPWpGaD
Degarelix—Hypersensitivity—Prednisone—multiple sclerosis	0.000606	0.000739	CcSEcCtD
Degarelix—Vomiting—Betamethasone—multiple sclerosis	0.0006	0.000732	CcSEcCtD
Degarelix—Vomiting—Dexamethasone—multiple sclerosis	0.0006	0.000732	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—multiple sclerosis	0.000597	0.000729	CcSEcCtD
Degarelix—Rash—Betamethasone—multiple sclerosis	0.000595	0.000726	CcSEcCtD
Degarelix—Rash—Dexamethasone—multiple sclerosis	0.000595	0.000726	CcSEcCtD
Degarelix—Dermatitis—Dexamethasone—multiple sclerosis	0.000595	0.000725	CcSEcCtD
Degarelix—Dermatitis—Betamethasone—multiple sclerosis	0.000595	0.000725	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000593	0.000724	CcSEcCtD
Degarelix—Fatigue—Methotrexate—multiple sclerosis	0.000592	0.000723	CcSEcCtD
Degarelix—Headache—Dexamethasone—multiple sclerosis	0.000592	0.000721	CcSEcCtD
Degarelix—Headache—Betamethasone—multiple sclerosis	0.000592	0.000721	CcSEcCtD
Degarelix—Asthenia—Prednisone—multiple sclerosis	0.00059	0.000719	CcSEcCtD
Degarelix—Pain—Methotrexate—multiple sclerosis	0.000588	0.000717	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000586	0.00366	CbGpPWpGaD
Degarelix—Pruritus—Prednisone—multiple sclerosis	0.000582	0.000709	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—multiple sclerosis	0.000566	0.000691	CcSEcCtD
Degarelix—Diarrhoea—Prednisone—multiple sclerosis	0.000563	0.000686	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000562	0.000685	CcSEcCtD
Degarelix—Nausea—Betamethasone—multiple sclerosis	0.000561	0.000684	CcSEcCtD
Degarelix—Nausea—Dexamethasone—multiple sclerosis	0.000561	0.000684	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCL5—multiple sclerosis	0.000554	0.00346	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000549	0.00343	CbGpPWpGaD
Degarelix—Urticaria—Methotrexate—multiple sclerosis	0.000546	0.000666	CcSEcCtD
Degarelix—Dizziness—Prednisone—multiple sclerosis	0.000544	0.000663	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—multiple sclerosis	0.000543	0.000663	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—multiple sclerosis	0.000543	0.000663	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000542	0.00338	CbGpPWpGaD
Degarelix—Vomiting—Prednisone—multiple sclerosis	0.000523	0.000638	CcSEcCtD
Degarelix—Rash—Prednisone—multiple sclerosis	0.000518	0.000632	CcSEcCtD
Degarelix—Dermatitis—Prednisone—multiple sclerosis	0.000518	0.000632	CcSEcCtD
Degarelix—Headache—Prednisone—multiple sclerosis	0.000515	0.000628	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—multiple sclerosis	0.000506	0.000617	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCL3—multiple sclerosis	0.000506	0.00316	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR5—multiple sclerosis	0.000499	0.00312	CbGpPWpGaD
Degarelix—Asthenia—Methotrexate—multiple sclerosis	0.000493	0.000601	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000492	0.00307	CbGpPWpGaD
Degarelix—Nausea—Prednisone—multiple sclerosis	0.000488	0.000596	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PTGER4—multiple sclerosis	0.000487	0.00304	CbGpPWpGaD
Degarelix—Pruritus—Methotrexate—multiple sclerosis	0.000486	0.000593	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PGR—multiple sclerosis	0.00048	0.00299	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CXCR3—multiple sclerosis	0.00047	0.00294	CbGpPWpGaD
Degarelix—Diarrhoea—Methotrexate—multiple sclerosis	0.00047	0.000573	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CD28—multiple sclerosis	0.000466	0.00291	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR2—multiple sclerosis	0.000457	0.00286	CbGpPWpGaD
Degarelix—Dizziness—Methotrexate—multiple sclerosis	0.000454	0.000554	CcSEcCtD
Degarelix—Vomiting—Methotrexate—multiple sclerosis	0.000437	0.000533	CcSEcCtD
Degarelix—Rash—Methotrexate—multiple sclerosis	0.000433	0.000528	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—multiple sclerosis	0.000433	0.000528	CcSEcCtD
Degarelix—Headache—Methotrexate—multiple sclerosis	0.000431	0.000525	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—POMC—multiple sclerosis	0.000429	0.00268	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CNR1—multiple sclerosis	0.000422	0.00264	CbGpPWpGaD
Degarelix—Nausea—Methotrexate—multiple sclerosis	0.000408	0.000498	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—POMC—multiple sclerosis	0.00039	0.00244	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL2—multiple sclerosis	0.000382	0.00238	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CXCL10—multiple sclerosis	0.00038	0.00237	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—TYK2—multiple sclerosis	0.000346	0.00216	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CD86—multiple sclerosis	0.000332	0.00208	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL5—multiple sclerosis	0.000327	0.00204	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—IL2—multiple sclerosis	0.000317	0.00198	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SPP1—multiple sclerosis	0.000303	0.00189	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR5—multiple sclerosis	0.000295	0.00184	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL2RA—multiple sclerosis	0.000291	0.00181	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL2—multiple sclerosis	0.000288	0.0018	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOE—multiple sclerosis	0.000268	0.00167	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CD80—multiple sclerosis	0.000242	0.00151	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—POMC—multiple sclerosis	0.00023	0.00144	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL2—multiple sclerosis	0.000225	0.00141	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000221	0.00138	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TYK2—multiple sclerosis	0.000205	0.00128	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL2—multiple sclerosis	0.00017	0.00106	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL6—multiple sclerosis	0.000169	0.00106	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MMP9—multiple sclerosis	0.000161	0.00101	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—STAT3—multiple sclerosis	0.000143	0.000895	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MYC—multiple sclerosis	0.000133	0.000832	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TGFB1—multiple sclerosis	0.000133	0.00083	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MAPK1—multiple sclerosis	0.00013	0.000814	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6—multiple sclerosis	0.0001	0.000625	CbGpPWpGaD
